Informed-money record
ARWR · Arrowhead Pharmaceuticals Inc.
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
0
Bearish filings
107
Named actors
21
Disclosed $ (bull / bear)
$0 / $261.0M
Recent disclosures
25 of 107 in the window · linked to source| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-05-19 | Officer (via Merrill Lynch) James Hamilton | filed notice to sell | $750K | SEC ↗ |
| 2026-05-19 | Officer (via Merrill Lynch) Hongbo Lu | filed notice to sell | $228K | SEC ↗ |
| 2026-05-19 | Officer (via Merrill Lynch) Daniel Apel | filed notice to sell | $934K | SEC ↗ |
| 2026-05-12 | Director Lu Hongbo | sold | $228K | SEC ↗ |
| 2026-05-07 | Board Member Adeoye Olukotun | adopted a selling plan | — | SEC ↗ |
| 2026-05-07 | Board Member Victoria Vakiener | adopted a selling plan | — | SEC ↗ |
| 2026-05-07 | Chief Financial Officer Daniel Apel | adopted a selling plan | — | SEC ↗ |
| 2026-05-07 | Board Member William Waddill | adopted a selling plan | — | SEC ↗ |
| 2026-05-07 | Board Member Hongbo Lu | adopted a selling plan | — | SEC ↗ |
| 2026-04-23 | Chief Medical Officer Hamilton James C | sold | $750K | SEC ↗ |
| 2026-04-22 | Chief Financial Officer Apel Daniel Joseph | sold | $628K | SEC ↗ |
| 2026-04-22 | Chief Financial Officer Apel Daniel Joseph | sold | $82K | SEC ↗ |
| 2026-04-22 | Chief Financial Officer Apel Daniel Joseph | sold | $225K | SEC ↗ |
| 2026-03-05 | Officer (via Merrill Lynch) James Hamilton | filed notice to sell | $642K | SEC ↗ |
| 2026-03-05 | Chief Medical Officer Hamilton James C | sold | $642K | SEC ↗ |
| 2026-02-05 | Chief Medical Officer, Head of R&D James Hamilton | adopted a selling plan | — | SEC ↗ |
| 2026-02-05 | President and Chief Executive Officer Christopher Anzalone | adopted a selling plan | — | SEC ↗ |
| 2026-01-05 | COO O'Brien Patrick | sold | $3K | SEC ↗ |
| 2026-01-05 | COO O'Brien Patrick | sold | $150K | SEC ↗ |
| 2026-01-05 | COO O'Brien Patrick | sold | $56K | SEC ↗ |
| 2026-01-05 | COO O'Brien Patrick | sold | $847K | SEC ↗ |
| 2026-01-05 | COO O'Brien Patrick | sold | $384K | SEC ↗ |
| 2026-01-05 | COO O'Brien Patrick | sold | $21K | SEC ↗ |
| 2026-01-05 | COO O'Brien Patrick | sold | $267K | SEC ↗ |
| 2026-01-05 | COO O'Brien Patrick | sold | $756K | SEC ↗ |
82 more disclosures in the window — the full record, scoring, and validation are for members.
Want the read, not just the record?
Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.
Create a free account →Dispute or correct this record
Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals